Presentation is loading. Please wait.

Presentation is loading. Please wait.

Swain 23 Oct. 02 1 Embol-X Clinical Reviewers Wolf Sapirstein M.D. Julie Swain M.D. (Cardiothoracic Surgery)

Similar presentations


Presentation on theme: "Swain 23 Oct. 02 1 Embol-X Clinical Reviewers Wolf Sapirstein M.D. Julie Swain M.D. (Cardiothoracic Surgery)"— Presentation transcript:

1 Swain 23 Oct. 02 1 Embol-X Clinical Reviewers Wolf Sapirstein M.D. Julie Swain M.D. (Cardiothoracic Surgery)

2 Swain 23 Oct. 02 2 Study Design Randomized, multicenter Control 644 patients, Filter 645 patients Control arm = patients without filter Interim data analysis at 50% of patients

3 Swain 23 Oct. 02 3 Investigational Plan “If the hypothesis tests performed at the interim are statistically significant, indicating emboli capture and equivalent safety, the study will be terminated” The study was continued to completion to attempt to show safety superiority (which was not shown)

4 Swain 23 Oct. 02 4 Inclusion/Exclusion Criteria Elective operations Isolated CAB or valve Age >60 Total 24 exclusion criteria – Neurological deficit – Hx major stroke (as defined by a clinical history of fixed, focal neurological deficit attributable to stroke) – Redo operations – Renal failure on dialysis

5 Swain 23 Oct. 02 5 Neurological Evaluation (Gross Neurologic Testing) History, Physical Exam NIH Stroke Score No neuropsychological testing

6 Swain 23 Oct. 02 6 Endpoints Efficacy: >75% of filters trap at least one particle Composite Primary Safety: 12 items (Not worse than control group with an equivalency delta of 5%) Secondary Safety: Aortic Injury (not part of composite safety endpoint)

7 Swain 23 Oct. 02 7 Patient Demographics No statistical differences in baseline characteristics between treatment and control group Treatment group: – 73% male –91% Caucasian –Average age 71 years

8 Swain 23 Oct. 02 8 Types of operations CABG AVR MVR/R 8% 6% 84%

9 Swain 23 Oct. 02 9 Composite Safety Endpoint (12 clinical events) Death Neurological Stroke TIA Non-metabolic coma Renal Creatinine >2.0 or increased 50% (non-dialysis) Dialysis Gastrointestinal Bleeding requiring transfusion Pancreatitis Cholecystitis Mesenteric ischemia Cardiac Q-wave MI Non Q-wave MI Limb threatening periph. embolism Diminished pulse Altered pallor Pain

10 Swain 23 Oct. 02 10 Number of Particles Trapped % filters 0 1-5 6-10 11-20 >20 Maximum number trapped = 25 (38 in roll-in) Total number of particles embolized unknown Mean 5.6 particles/filter

11 Swain 23 Oct. 02 11 Selected Events % patients * * P <.001

12 Swain 23 Oct. 02 12 Manipulation-Related Aortic Injury Filter Roll In Filter Control % patients * * p<0.001 vs control 7/7842/456 9/454

13 Swain 23 Oct. 02 13 Manipulation-Related Aortic Injury Occurred in 9.2% of filter patients (42/456 patients) 3 filter patients required aortic repair Study protocol follow-up: 30 day or hospital discharge, whichever occurred first (median follow-up 7.0 days) Post hoc designed telephone follow-up of 43/49 aortic injury patients (roll in + randomized), 18/49 had > 1 year follow-up No apparent training effect Not associated with increase in Adverse Events

14 Swain 23 Oct. 02 14 Post-Hoc Data Analysis These analyses were not planned prospectively in the investigational plan Statistical treatment of post hoc analyses is not straight-forward  Nominal p-values do not account for multiplicity  No way to know how much adjustment should be applied when judging "significance"

15 Swain 23 Oct. 02 15 Selected Adverse Events (Higgins score >5) % patients p = N.S. for all points 4 5 8 6 4 6 5 3

16 Swain 23 Oct. 02 16 Summary Embol-XControlp value Trapped at least one particle 97% Composite safety endpoint 17.1%18.9%n.s. Individual safety eventsn.s. Aortic injuries9.2%2.0%<.001

17 Swain 23 Oct. 02 17 Conclusions The filter traps particles A correlation with clinical improvement was not shown Additional concerns were raised by the occurrence of aortic injuries


Download ppt "Swain 23 Oct. 02 1 Embol-X Clinical Reviewers Wolf Sapirstein M.D. Julie Swain M.D. (Cardiothoracic Surgery)"

Similar presentations


Ads by Google